The reversible inhibition of myoblast fusion by ethidium bromide (EB).
D002459:Cell Fusion / Q000187:drug effects*; D002478:Cells, Cultured; D002701:Chloramphenicol / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D004996:Ethidium / Q000494:pharmacology*; D005467:Floxuridine / Q000494:pharmacology; D006918:Hydroxyurea / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology; D013936:Thymidine / Q000494:pharmacology
D005467:Floxuridine; D003561:Cytarabine; D012313:RNA; D002701:Chloramphenicol; D004247:DNA; D004996:Ethidium; D013936:Thymidine; D012293:Rifampin; D006918:Hydroxyurea; D008727:Methotrexate